Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Acurx Pharmaceuticals Inc (NASDAQ: ACXP) was $3.75 for the day, down -3.10% from the previous closing price of $3.87. In other words, the price has decreased by -$3.10 from its previous closing price. On the day, 51362.0 shares were traded. ACXP stock price reached its highest trading level at $4.06 during the session, while it also had its lowest trading level at $3.75.
Ratios:
Our analysis of ACXP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.47 and its Current Ratio is at 2.47. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 06 ’25 when Scodari Joseph C bought 24,631 shares for $1.01 per share. The transaction valued at 25,000 led to the insider holds 27,708 shares of the business.
Sailer Carl bought 24,631 shares of ACXP for $25,000 on Jan 06 ’25. The Director now owns 137,183 shares after completing the transaction at $1.01 per share. On Jan 06 ’25, another insider, LUCI DAVID P, who serves as the President and CEO of the company, bought 49,261 shares for $1.01 each. As a result, the insider paid 50,000 and bolstered with 1,097,458 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACXP now has a Market Capitalization of 7820111 and an Enterprise Value of 1913309.
Stock Price History:
The Beta on a monthly basis for ACXP is -1.22, which has changed by -0.8452 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, ACXP has reached a high of $26.60, while it has fallen to a 52-week low of $3.80. The 50-Day Moving Average of the stock is -28.74%, while the 200-Day Moving Average is calculated to be -49.57%.
Shares Statistics:
ACXP traded an average of 568.49K shares per day over the past three months and 52380 shares per day over the past ten days. A total of 2.09M shares are outstanding, with a floating share count of 1.92M. Insiders hold about 8.12% of the company’s shares, while institutions hold 7.03% stake in the company. Shares short for ACXP as of 1763078400 were 36396 with a Short Ratio of 0.06, compared to 1760486400 on 116032. Therefore, it implies a Short% of Shares Outstanding of 36396 and a Short% of Float of 1.76.
Earnings Estimates
The stock of Acurx Pharmaceuticals Inc (ACXP) is currently drawing attention from 2.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.94, with high estimates of -$0.94 and low estimates of -$0.94.
Analysts are recommending an EPS of between -$5.7 and -$5.72 for the fiscal current year, implying an average EPS of -$5.71. EPS for the following year is -$3.7, with 2.0 analysts recommending between -$2.75 and -$4.66.
